Newspaper Publication under Regulation 30 and 47 of Listing Regulations.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health (Medanta) published its audited Q4 and full-year FY26 results in newspapers per SEBI listing regulations. Consolidated revenue grew 19.5% YoY to ₹44,103 million, with Q4 revenue at ₹11,590 million vs ₹9,313 million a year ago. Net profit after tax for FY26 stood at ₹5,541 million, up 15.1% from ₹4,813 million. Consolidated EPS (basic) for the year was ₹20.71. The standalone FY26 net profit after tax was ₹4,962 million. Results were reviewed by the Audit Committee and approved by the Board on May 14, 2026.
Strong revenue and profit growth for FY26 with both consolidated and standalone metrics showing double-digit expansion, which is positive for shareholders. The Q4 and full-year beat on revenue growth indicates continued operational momentum.